Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Goldman Sachs ajuste sa position sur Valneva ce jeudi 5 février 2026.
Valneva's stock recorded a 3.13% increase at midday on Wednesday, February 4, 2026, reaching 4.026 euros. The biotech company, specializing in vaccine…
Valneva SE and the Instituto Butantan announce the initiation of a pilot vaccination campaign in Brazil using IXCHIQ®, a single-dose vaccine against c…
Valneva, a French vaccine specialist, closed the week at 3.89 euros, marking a decline of 11.35%. This correction follows an annual increase of 64.61%…
Valneva's stock closed the session on Wednesday, January 28, 2026, at 3.99 euros, down by 2.45% compared to the previous day. This decline is part of …
Valneva's stock fell by 6.38% to 4.106 euros on Monday, January 26, at midday, amidst the backdrop of the voluntary withdrawal announced on January 19…
Valneva's stock closed up 3.93% at 4.386 euros this Thursday, January 22, after experiencing a significant decline earlier in the week. The company an…
French laboratory Valneva is down 3.93% at 4.16 euros this Wednesday midday, marking one of the steepest declines in the SBF 120. This stock market se…
Valneva's stock recorded a morning drop of 8.5% on January 20, ranking among the largest declines in the SBF 120, before rebounding at the close to ul…
French laboratory Valneva announced on Sunday the voluntary withdrawal of its market authorization and clinical trial applications in the United State…
